No Shortage of Hepatitis C Treatments

Daklinza is a prescription drug used to treat genotype 3 chronic hepatitis C virus (HCV) infection. It is given in combination with sofosbuvir for 12 weeks. Daklinza belongs to a group of drugs called NS5A inhibitors, which help stop the virus from spreading. This medication comes in tablet form and is taken once daily, either with or without food. The FDA approved Daklinza in July 2015.